|
CDC23 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.267820E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.387400E-01 |
| Normal-vs-Stage2 |
9.065200E-01 |
| Normal-vs-Stage3 |
6.100100E-03 |
| Normal-vs-Stage4 |
9.205000E-03 |
| Stage1-vs-Stage2 |
9.372600E-01 |
| Stage1-vs-Stage3 |
5.358000E-03 |
| Stage1-vs-Stage4 |
1.217790E-02 |
| Stage2-vs-Stage3 |
5.332500E-02 |
| Stage2-vs-Stage4 |
5.663900E-02 |
| Stage3-vs-Stage4 |
9.768000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.153800E-01 |
| Normal-vs-AfricanAmerican |
2.789900E-02 |
| Normal-vs-Asian |
2.508200E-01 |
| Caucasian-vs-AfricanAmerican |
1.847780E-01 |
| Caucasian-vs-Asian |
7.113200E-01 |
| AfricanAmerican-vs-Asian |
8.623800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.335100E-03 |
| Normal-vs-Female |
4.992400E-01 |
| Male-vs-Female |
2.902700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.600790E-04 |
| Normal-vs-Age(41-60Yrs) |
4.288000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.495370E-01 |
| Normal-vs-Age(81-100Yrs) |
9.492200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.860300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.154480E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.942100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.933600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.012000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.958200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.384210E-01 |
| Normal-vs-Grade 2 |
6.894400E-01 |
| Normal-vs-Grade 3 |
7.941700E-02 |
| Normal-vs-Grade 4 |
4.04870000003665E-06 |
| Grade 1-vs-Grade 2 |
3.156000E-01 |
| Grade 1-vs-Grade 3 |
4.851800E-02 |
| Grade 1-vs-Grade 4 |
5.234300E-04 |
| Grade 2-vs-Grade 3 |
4.577500E-02 |
| Grade 2-vs-Grade 4 |
2.52540000000856E-06 |
| Grade 3-vs-Grade 4 |
1.815650E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.443900E-03 |
| Normal-vs-ccB subtype |
4.06509999995031E-06 |
| ccA subtype-vs-ccB subtype |
8.7984064478519E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.896600E-01 |
| Normal-vs-N1 |
1.497970E-01 |
| N0-vs-N1 |
1.950750E-01 |
|
|
